title: Mechanism and thermodynamics of guanidinium chloride-induced denaturation of ALS-associated mutant Cu,Zn superoxide dismutases.
abstract: Mutations in human copper zinc superoxide dismutase (hSOD) that are associated with amyotrophic lateral sclerosis (ALS) have been proposed to destabilize the protein and thereby enhance toxic protein aggregation. In previous studies, denaturation of metallated (holo) hSODs was found to be irreversible, and complicated by the formation of intermolecular disulfide bonds. Here, ALS-associated mutations (E100G, G93A, G85R and A4V) are introduced into a pseudo wild-type background containing no free cysteine residues. The guanidinium chloride-induced denaturation of the holo proteins is generally found to be highly reversible (except for A4V, which tended to aggregate), enabling quantitative analysis of the effects of the mutations on protein stability. Denaturation and renaturation curves were monitored by tryptophan fluorescence, circular dichroism, enzyme activity, chemical cross-linking and analytical sedimentation, as a function of equilibration time and protein concentration. There is strong kinetic hysteresis, with curves requiring exceptionally long times (many days for pseudo wild-type) to reach equilibrium, and evidence for the formation of kinetic and equilibrium intermediate(s), which are more highly populated at lower protein concentrations. The effects of metal dissociation were included in the data fitting. The full protein concentration dependence is best described using a three-state model involving metallated native dimer, metallated monomeric intermediate and unfolded monomers with no bound metals; however, at high protein concentrations the unfolding approaches a two-state transition with metal binding to both the native dimers and unfolded monomers. We show that the E100G, G93A and G85R mutations decrease overall protein stability, largely by decreasing monomer stability with little effect on dimer dissociation. Comparison of the chemical denaturation data with ALS disease characteristics suggests that aggregation of some mutant hSOD may occur through increased population of partially folded states that are less stable than the monomeric intermediate and accessed from the destabilized holo protein.
authors.affiliation: Guelph-Waterloo Centre for Graduate Work in Chemistry and Biochemistry and Department of Chemistry, University of Waterloo, Waterloo, Ont. Canada N2L 3G1.
authors.forename: Jessica A O
authors.initials: JA
authors.lastname: Rumfeldt
authors.forename: Peter B
authors.initials: PB
authors.lastname: Stathopulos
authors.forename: Avijit
authors.initials: A
authors.lastname: Chakrabarrty
authors.forename: James R
authors.initials: JR
authors.lastname: Lepock
authors.forename: Elizabeth M
authors.initials: EM
authors.lastname: Meiering
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D019791:Guanidine / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D009154:Mutation; D011489:Protein Denaturation / Q000187:drug effects; D020673:Protein Renaturation; D013482:Superoxide Dismutase / Q000737:chemistry* / Q000235:genetics*; D013816:Thermodynamics
chemical_list: D013482:Superoxide Dismutase; D019791:Guanidine